This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Albrektsen, G. Articles by Kvåle, G. Search for Related Content PubMed PubMed Citation Articles by Albrektsen, G. Articles by Kvåle, G.

Clinical Stage of Breast Cancer by Parity, Age at Birth, and Time Since Birth: A Progressive Effect of Pregnancy Hormones?

¹ Department of Mathematics and ² Center for International Health, University of Bergen, Bergen, Norway; and ³ Cancer Registry of Norway, Oslo, Norway

Requests for reprints: Grethe Albrektsen, Department of Mathematics, University of Bergen, Johannes Bruns gate 12, 5008 Bergen, Norway. Phone: 47-555-82686; Fax: 47-555-89672. E-mail: msega@uib.no

Breast cancer diagnosed during pregnancy or 1 to 2 years after birth often occurs at a late stage. Little is known about tumor characteristics in the high-risk period shortly after a childbirth. We here explore whether stage of disease differs according to timing of births. Results are based on 22,351 Norwegian breast cancer patients of parity 0 to 5, ages 20 to 74 years. The proportion of stage II to IV tumors was considerably higher among parous than nulliparous women at age <30 years (52.7% versus 36.8%, P = 0.009), but similar or lower in other age groups (P_interaction = 0.029). In general, the largest proportion of stage II to IV tumors was found among women diagnosed during pregnancy or <2 years after birth. However, among women with late-age births (first or second birth 30 years, third birth 35 years), as well as women with an early second birth (<25 years), the proportion with advanced disease was rather similar or even higher among those diagnosed 2 to 6 years after birth (49.3-56.0%). The association between clinical stage and time since birth reached statistical significance among women with a late first or second birth and among all triparous women (P 0.032). The subgroups with a high proportion of advanced disease 2 to 6 years after birth corresponded quite well to those previously found to have the most pronounced transient increase in risk after birth. Thus, pregnancy hormones may have a progressive effect on breast cancer tumors in addition to a possible promoting effect. A potential effect of prolactin is discussed. (Cancer Epidemiol Biomarkers Prev 2006;(15)1:65–9)

This article has been cited by other articles:

				L. Dodds, D. B. Fell, K. S. Joseph, R. Dewar, H. Scott, R. Platt, and K. J. Aronson Relationship of Time Since Childbirth and Other Pregnancy Factors to Premenopausal Breast Cancer Prognosis Obstet. Gynecol., May 1, 2008; 111(5): 1167 - 1173. [Abstract] [Full Text] [PDF]

				L. C. Hartmann, T. R. Milanese, C. M. Vachon, and R. A. Vierkant Response: Re: Age-Related Lobular Involution and Risk of Breast Cancer J Natl Cancer Inst, April 4, 2007; 99(7): 572 - 572. [Full Text] [PDF]

				G. Ferretti, A. Felici, and F. Cognetti Pregnancy Levels of Estrogen and Progesterone: The Double-Edged Sword Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 634 - 634. [Full Text] [PDF]

				G. Albrektsen, I. Heuch, S. Thoresen, and G. Kvale Pregnancy Levels of Estrogen and Progesterone: The Double-Edged Sword Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 634 - 634. [Full Text] [PDF]